Maze Therapeutics (MAZE) Equity Ratio (2024 - 2025)
Maze Therapeutics has reported Equity Ratio over the past 2 years, most recently at 0.89 for Q4 2025.
- Quarterly Equity Ratio rose 169.09% to 0.89 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.89 through Dec 2025, up 169.09% year-over-year, with the annual reading at 0.89 for FY2025, 169.09% up from the prior year.
- Equity Ratio was 0.89 for Q4 2025 at Maze Therapeutics, down from 0.9 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.9 in Q3 2025 and troughed at 1.29 in Q4 2024.